Arvinas Correlations

ARVN Stock

USD 17.14 0.53 3.00%

The current 90-days correlation between Arvinas and Nurix Therapeutics is 0.26 (i.e., Modest diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Arvinas moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Arvinas moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Arvinas Correlation With Market

Modest diversification

The correlation between Arvinas and DJI is 0.26 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Arvinas and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arvinas. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

To learn how to invest in Arvinas Stock, please use our How to Invest in Arvinas guide.

Moving together with Arvinas Stock

0.7	EDIT	Editas Medicine Earnings Call Today	Pair Corr
0.9	FATE	Fate Therapeutics	Pair Corr
0.78	NVO	Novo Nordisk AS	Pair Corr
0.68	KURA	Kura Oncology	Pair Corr
0.86	NTLA	Intellia Therapeutics	Pair Corr
0.84	REGN	Regeneron Pharmaceuticals	Pair Corr
0.86	ABOS	Acumen Pharmaceuticals	Pair Corr
0.86	ADTX	Aditxt Inc	Pair Corr
0.79	ANAB	AnaptysBio	Pair Corr
0.93	STRO	Sutro Biopharma	Pair Corr
0.92	TCRX	Tscan Therapeutics	Pair Corr
0.63	TERN	Terns Pharmaceuticals	Pair Corr

Moving against Arvinas Stock

0.58	PFE	Pfizer Inc Aggressive Push	Pair Corr
0.51	OPT	Opthea Earnings Call Today	Pair Corr
0.49	GANX	Gain Therapeutics	Pair Corr
0.49	TMO	Thermo Fisher Scientific	Pair Corr
0.47	LTRN	Lantern Pharma	Pair Corr
0.45	XFOR	X4 Pharmaceuticals	Pair Corr
0.41	CUE	Cue Biopharma	Pair Corr
0.4	FENC	Fennec Pharmaceuticals	Pair Corr
0.36	VERV	Verve Therapeutics	Pair Corr
0.35	NAMSW	NewAmsterdam Pharma Upward Rally	Pair Corr
0.31	A	Agilent Technologies Earnings Call Today	Pair Corr
0.74	CGTX	Cognition Therapeutics	Pair Corr
0.57	PHGE	Biomx Inc	Pair Corr
0.5	DBVT	DBV Technologies Earnings Call This Week	Pair Corr
0.32	BNTC	Benitec Biopharma	Pair Corr

Related Correlations Analysis

	CCCC	GLUE	NRIX	FHTX	RLAY	STOK	PLRX	BDTX	STTK	KYMR
CCCC		0.66	0.88	0.47	0.67	0.61	0.83	0.38	-0.45	0.84	CCCC
GLUE	0.66		0.68	0.82	0.29	0.72	0.5	0.45	-0.23	0.69	GLUE
NRIX	0.88	0.68		0.57	0.7	0.6	0.79	0.54	-0.51	0.86	NRIX
FHTX	0.47	0.82	0.57		0.19	0.42	0.16	0.37	-0.27	0.55	FHTX
RLAY	0.67	0.29	0.7	0.19		0.4	0.67	0.6	-0.3	0.67	RLAY
STOK	0.61	0.72	0.6	0.42	0.4		0.54	0.55	-0.17	0.47	STOK
PLRX	0.83	0.5	0.79	0.16	0.67	0.54		0.27	-0.4	0.75	PLRX
BDTX	0.38	0.45	0.54	0.37	0.6	0.55	0.27		-0.27	0.49	BDTX
STTK	-0.45	-0.23	-0.51	-0.27	-0.3	-0.17	-0.4	-0.27		-0.47	STTK
KYMR	0.84	0.69	0.86	0.55	0.67	0.47	0.75	0.49	-0.47		KYMR
	CCCC	GLUE	NRIX	FHTX	RLAY	STOK	PLRX	BDTX	STTK	KYMR

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

NRIX	+ 0.88	CCCC
KYMR	+ 0.86	NRIX
KYMR	+ 0.84	CCCC
PLRX	+ 0.83	CCCC
FHTX	+ 0.82	GLUE
PLRX	+ 0.79	NRIX

High negative correlations

STTK	- 0.51	NRIX
KYMR	- 0.47	STTK
STTK	- 0.45	CCCC
STTK	- 0.4	PLRX
STTK	- 0.3	RLAY
STTK	- 0.27	BDTX

Risk-Adjusted Indicators

There is a big difference between Arvinas Stock performing well and Arvinas Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Arvinas' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
CCCC	3.58	(0.54)	0.00	(0.29)	0.00	0.00	8.02	(6.03)	22.96
GLUE	3.77	(0.30)	0.00	(0.21)	0.00	0.00	8.40	(8.27)	23.57
NRIX	2.34	(0.39)	0.00	(0.45)	0.00	0.00	4.59	(4.61)	13.29
FHTX	3.61	(0.53)	0.00	(0.26)	0.00	0.00	9.05	(8.30)	23.64
RLAY	3.71	(0.33)	0.00	(0.31)	0.00	0.00	7.42	(7.02)	24.83
STOK	3.37	(0.42)	0.00	6.99	0.00	0.00	7.03	(9.08)	27.59
PLRX	4.91	(1.34)	0.00	(1.09)	0.00	0.00	10.38	(8.16)	72.98
BDTX	3.54	(0.22)	0.00	(0.19)	0.00	0.00	5.02	(6.45)	29.04
STTK	4.71	0.68	0.12	(1.15)	4.72	(5.87)	11.21	(8.40)	20.39
KYMR	2.76	(0.26)	0.00	(0.15)	0.00	0.00	5.88	(6.47)	16.08

Arvinas Corporate Management

CPA CPA	CFO Treasurer	Profile
Ian Taylor	Chief Scientific Officer	Profile
Paul McInulty	Senior Affairs	Profile
Matthew JD	Gen Sec	Profile
John Grosso	Senior Operations	Profile
Randy Teel	Senior Development	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC